NYSE:CVS - CVS Health Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$65.62 +0.12 (+0.18 %)
(As of 05/22/2018 04:00 PM ET)
Previous Close$65.62
Today's Range$65.42 - $66.59
52-Week Range$60.14 - $84.00
Volume4.18 million shs
Average Volume8.88 million shs
Market Capitalization$66.00 billion
P/E Ratio11.12
Dividend Yield3.08%
Beta1.02

About CVS Health (NYSE:CVS)

CVS Health logoCVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:CVS
CUSIP12665010
Phone401-765-1500

Debt

Debt-to-Equity Ratio1.59
Current Ratio2.37
Quick Ratio1.88

Price-To-Earnings

Trailing P/E Ratio11.12
Forward P/E Ratio9.39
P/E Growth0.97

Sales & Book Value

Annual Sales$184.77 billion
Price / Sales0.36
Cash Flow$8.6799 per share
Price / Cash7.56
Book Value$37.21 per share
Price / Book1.76

Profitability

EPS (Most Recent Fiscal Year)$5.90
Net Income$6.62 billion
Net Margins3.59%
Return on Equity17.45%
Return on Assets6.10%

Miscellaneous

Employees246,000
Outstanding Shares1,016,650,000

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Tuesday, March 13th. Investors of record on Monday, April 23rd will be given a dividend of $0.50 per share on Thursday, May 3rd. This represents a $2.00 annualized dividend and a yield of 3.05%. The ex-dividend date of this dividend is Friday, April 20th. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health (NYSE:CVS) issued its earnings results on Wednesday, May, 2nd. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.09. The pharmacy operator had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.77 billion. CVS Health had a net margin of 3.59% and a return on equity of 17.45%. The company's revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.17 earnings per share. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for CVS Health.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided EPS guidance of $6.87-7.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.45. CVS Health also updated its Q2 guidance to $1.59-1.64 EPS.

What price target have analysts set for CVS?

19 brokerages have issued 12 month price targets for CVS Health's shares. Their predictions range from $68.00 to $99.00. On average, they expect CVS Health's stock price to reach $86.8750 in the next twelve months. View Analyst Ratings for CVS Health.

Are investors shorting CVS Health?

CVS Health saw a increase in short interest in April. As of April 30th, there was short interest totalling 44,363,884 shares, an increase of 2.4% from the April 13th total of 43,345,137 shares. Based on an average daily volume of 9,913,915 shares, the days-to-cover ratio is currently 4.5 days. Approximately 4.4% of the shares of the stock are sold short.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:
  • Mr. Larry J. Merlo, Pres, CEO & Director (Age 62)
  • Mr. David M. Denton, Exec. VP & CFO (Age 53)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 62)
  • Mr. Thomas Michael Moriarty, Exec. VP, Gen. Counsel and Chief of Policy & External Affairs Officer (Age 54)
  • Ms. Eva C. Boratto, Exec. VP, Controller & Chief Accounting Officer (Age 51)

Has CVS Health been receiving favorable news coverage?

News coverage about CVS stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CVS Health earned a media sentiment score of 0.24 on Accern's scale. They also assigned media coverage about the pharmacy operator an impact score of 45.85 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.89%), Barrow Hanley Mewhinney & Strauss LLC (1.78%), Northern Trust Corp (1.52%), Franklin Resources Inc. (1.20%), Veritas Asset Management LLP (1.12%) and Dimensional Fund Advisors LP (1.06%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Which institutional investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Prudential Financial Inc., Element Capital Management LLC, The Manufacturers Life Insurance Company , Boston Partners, Lord Abbett & CO. LLC, Crawford Investment Counsel Inc. and Equity Investment Corp. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

Which institutional investors are buying CVS Health stock?

CVS stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Schwab Charles Investment Management Inc., Carmignac Gestion, Barrow Hanley Mewhinney & Strauss LLC, Rockefeller Capital Management L.P., Millennium Management LLC, Russell Investments Group Ltd. and Toronto Dominion Bank. View Insider Buying and Selling for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $65.62.

How big of a company is CVS Health?

CVS Health has a market capitalization of $66.00 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (CVS)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  944 (Vote Outperform)
Underperform Votes:  440 (Vote Underperform)
Total Votes:  1,384
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CVS Health (NYSE:CVS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
19 Wall Street analysts have issued ratings and price targets for CVS Health in the last 12 months. Their average twelve-month price target is $86.8750, suggesting that the stock has a possible upside of 32.39%. The high price target for CVS is $99.00 and the low price target for CVS is $68.00. There are currently 6 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.792.802.802.65
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
11 Buy Rating(s)
2 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
12 Buy Rating(s)
2 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
12 Buy Rating(s)
2 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $86.8750$87.2353$88.4037$85.6483
Price Target Upside: 32.39% upside36.37% upside25.30% upside24.09% upside

CVS Health (NYSE:CVS) Consensus Price Target History

Price Target History for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/7/2018Loop CapitalSet Price TargetHold$68.00MediumView Rating Details
4/11/2018Bank of AmericaLower Price TargetBuy ➝ Buy$91.00 ➝ $88.00LowView Rating Details
4/10/2018Leerink SwannSet Price TargetBuy$85.00LowView Rating Details
2/13/2018CitigroupSet Price TargetNeutral ➝ Neutral$80.00 ➝ $77.00LowView Rating Details
2/9/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$85.00 ➝ $80.00LowView Rating Details
2/9/2018Needham & Company LLCSet Price TargetStrong-Buy ➝ Buy$100.00 ➝ $98.00MediumView Rating Details
2/8/2018Royal Bank of CanadaSet Price TargetBuy$89.00MediumView Rating Details
1/24/2018MizuhoSet Price TargetBuy$95.00LowView Rating Details
1/18/2018CowenReiterated RatingOutperform$81.00 ➝ $99.00LowView Rating Details
1/5/2018SunTrust BanksBoost Price TargetBuy$90.00HighView Rating Details
1/5/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$88.00HighView Rating Details
1/4/2018Raymond JamesUpgradeOutperform ➝ Strong-Buy$90.00HighView Rating Details
1/4/2018UBSUpgradeOutperform ➝ Strong-BuyHighView Rating Details
12/26/2017Tigress FinancialReiterated RatingBuyLowView Rating Details
12/5/2017Deutsche BankReiterated RatingBuy ➝ HoldMediumView Rating Details
12/4/2017Jefferies GroupSet Price TargetHold$76.00MediumView Rating Details
10/9/2017OppenheimerReiterated RatingBuy$95.00N/AView Rating Details
8/14/2017Wolfe ResearchDowngradeOutperform ➝ Market Perform$89.00 ➝ $82.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 ➝ $88.00LowView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight ➝ Neutral$84.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 ➝ $85.00N/AView Rating Details
11/9/2016BarclaysReiterated RatingBuy$85.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
(Data available from 5/22/2016 forward)

Earnings

CVS Health (NYSE:CVS) Earnings History and Estimates Chart

Earnings by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Earnings Estimates

2018 EPS Consensus Estimate: $6.76
2019 EPS Consensus Estimate: $7.13
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$1.10$1.49$1.29
Q2 20185$1.43$1.62$1.58
Q3 20184$1.69$1.82$1.76
Q4 20184$1.99$2.22$2.13
Q1 20192$1.24$1.51$1.38
Q2 20192$1.59$1.69$1.64
Q3 20191$1.78$1.78$1.78
Q4 20191$2.33$2.33$2.33

CVS Health (NYSE CVS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2018$1.61N/AView Earnings Details
5/2/2018Q1 2018$1.39$1.48$45.7746 billion$45.6930 billionViewN/AView Earnings Details
2/8/2018Q4 2017$1.88$1.92$47.5388 billion$48.3850 billionViewListenView Earnings Details
11/6/2017Q3 2017$1.49$1.50$46.1740 billion$46.1810 billionViewN/AView Earnings Details
8/8/2017Q2 2017$1.31$1.33$45.3553 billion$45.6850 billionViewListenView Earnings Details
5/2/2017Q1 2017$1.1030$1.17$44.2025 billion$44.5140 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.0880 billion$30.2270 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
2/8/2012Q4 2011$0.89$0.89ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
11/3/2010Q3 2010$0.64$0.65ViewN/AView Earnings Details
7/28/2010Q2 2010$0.68$0.65ViewN/AView Earnings Details
5/4/2010Q1 2010$0.58$0.60ViewN/AView Earnings Details
2/8/2010Q4 2009$0.78$0.79ViewN/AView Earnings Details
11/5/2009Q3 2009$0.64$0.65ViewN/AView Earnings Details
8/4/2009Q2 2009$0.64$0.65ViewN/AView Earnings Details
5/5/2009Q1 2009$0.54$0.55ViewN/AView Earnings Details
2/19/2009Q4 2008$0.69$0.70ViewN/AView Earnings Details
10/30/2008Q3 2008$0.59$0.60ViewN/AView Earnings Details
7/31/2008Q2 2008$0.60$0.60ViewN/AView Earnings Details
5/1/2008Q1 2008$0.54$0.55ViewN/AView Earnings Details
1/31/2008Q4 2007$0.55$0.58ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

CVS Health (NYSE:CVS) Dividend Information

CVS Health pays an annual dividend of $2.00 per share, with a dividend yield of 3.05%. CVS's most recent quarterly dividend payment was Thursday, May 3. The company has grown its dividend for the last 10 consecutive years and is increasing its dividend by an average of 22.10% each year. CVS Health pays out 33.90% of its earnings out as a dividend.
Most Recent Dividend:5/3/2018
Annual Dividend:$2.00
Dividend Yield:3.05%
Dividend Growth:22.10% (3 Year Average)
Payout Ratio(s):33.90% (Trailing 12 Months of Earnings)
28.61% (Based on This Year's Estimates)
28.05% (Based on Next Year's Estimates)
23.04% (Based on Cash Flow)
Track Record:10 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/13/2018quarterly$0.502.9655990510083%4/20/20184/23/20185/3/2018
12/29/2017quarterly$0.502.72%1/23/20181/24/20182/2/2018
9/19/2017quarterly$0.502.48%10/23/201710/24/201711/3/2017
7/6/2017quarterly$0.502.54%7/20/20177/24/20178/3/2017
3/2/2017quarterly$0.502.47%4/19/20174/21/20175/1/2017
12/22/2016quarterly$0.502.54%1/20/20171/24/20172/2/2017
9/22/2016quarterly$0.42501.88%10/20/201610/24/201611/3/2016
7/6/2016quarterly$0.42501.78%7/19/20167/21/20168/1/2016
3/2/2016quarterly$0.42501.71%4/20/20164/22/20165/2/2016
12/16/2015quarterly$0.42501.79%1/20/20161/22/20162/2/2016
10/1/2015quarterly$0.351.41%10/20/201510/22/201511/2/2015
7/8/2015quarterly$0.351.32%7/21/20157/23/20158/3/2015
3/4/2015quarterly$0.351.35%4/22/20154/24/20155/4/2015
12/17/2014quarterly$0.351.49%1/20/20151/22/20152/2/2015
9/24/2014quarterly$0.27501.38%10/21/201410/23/201411/3/2014
7/10/2014quarterly$0.27501.43%7/17/20147/21/20148/1/2014
3/6/2014quarterly$0.27501.5%4/17/20144/22/20145/2/2014
12/18/2013quarterly$0.27501.57%1/21/20141/23/20142/3/2014
9/25/2013quarterly$0.22501.55%10/17/201310/21/201311/1/2013
7/10/2013quarterly$0.22501.48%7/18/20137/22/20138/2/2013
3/6/2013quarterly$0.22501.73%4/19/20134/23/20135/3/2013
12/13/2012quarterly$0.22501.83%1/22/20131/24/20132/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

CVS Health (NYSE CVS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.53%
Institutional Ownership Percentage: 83.34%
Insider Trading History for CVS Health (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/4/2018C David Brown IIDirectorBuy10,000$61.99$619,900.00101,252View SEC Filing  
2/16/2018Helena FoulkesEVPSell19,965$71.04$1,418,313.6065,072View SEC Filing  
12/21/2017Lisa BisacciaEVPSell29,445$75.00$2,208,375.0015,556View SEC Filing  
10/2/2017Thomas M MoriartyEVPSell20,547$81.17$1,667,799.9943,178View SEC Filing  
9/18/2017Jonathan C RobertsCOOSell85,743$83.14$7,128,673.02119,555View SEC Filing  
9/15/2017Helena FoulkesEVPSell39,340$81.88$3,221,159.2084,337View SEC Filing  
9/13/2017Larry J MerloInsiderSell241,150$83.07$20,032,330.50299,255View SEC Filing  
9/11/2017David M DentonCFOSell237,078$79.65$18,883,262.70141,096View SEC Filing  
9/11/2017Thomas M MoriartyEVPSell90,267$79.61$7,186,155.8770,102View SEC Filing  
8/16/2017Richard J SwiftDirectorSell2,500$79.62$199,050.003,258View SEC Filing  
6/26/2017Helena FoulkesEVPSell20,333$80.00$1,626,640.0059,301View SEC Filing  
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.3659,300View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00176,983View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.7794,309View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.4041,614View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.6022,801View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24250,335View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.0089,955View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00280,381View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.0069,601View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.0042,048View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00261,287View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.3075,315View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02561,059View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00161,613View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.0043,858View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.086,998View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.1156,187View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.5085,869View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52219,871View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.1240,563View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00408,649View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.0027,233View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.0756,187View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.5019,448View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.007,897View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.203,128View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CVS Health (NYSE CVS) News Headlines

Source:
DateHeadline
CVS-Aetna, Cigna-Express Scripts Deals Will Consolidate Control Of Medicare Drug BenefitsCVS-Aetna, Cigna-Express Scripts Deals Will Consolidate Control Of Medicare Drug Benefits
www.forbes.com - May 22 at 3:07 PM
CVS-Aetna merger is not about the minute clinic, Aetna CEO saysCVS-Aetna merger is not about the minute clinic, Aetna CEO says
finance.yahoo.com - May 22 at 3:07 PM
Saks Fifth Avenue’s Beauty Business Gets a Big MakeoverSaks Fifth Avenue’s Beauty Business Gets a Big Makeover
finance.yahoo.com - May 21 at 3:11 PM
Comparing CVS Health (CVS) and Rite Aid (RAD)Comparing CVS Health (CVS) and Rite Aid (RAD)
www.americanbankingnews.com - May 20 at 9:53 AM
Resurgent Economy, Buyouts to Keep Health Insurers BuoyantResurgent Economy, Buyouts to Keep Health Insurers Buoyant
finance.yahoo.com - May 19 at 5:14 AM
CVS Health (CVS) Expected to Announce Quarterly Sales of $46.48 BillionCVS Health (CVS) Expected to Announce Quarterly Sales of $46.48 Billion
www.americanbankingnews.com - May 18 at 2:04 AM
Health Insurance Industry Outlook - May 2018Health Insurance Industry Outlook - May 2018
www.zacks.com - May 17 at 3:11 PM
Is CVS Health Corporation (NYSE:CVS) A Smart Pick For Income Investors?Is CVS Health Corporation (NYSE:CVS) A Smart Pick For Income Investors?
finance.yahoo.com - May 17 at 3:11 PM
Financial Review: CVS Health (CVS) and Diplomat Pharmacy (DPLO)Financial Review: CVS Health (CVS) and Diplomat Pharmacy (DPLO)
www.americanbankingnews.com - May 17 at 6:06 AM
$1.51 EPS Expected for CVS Health (CVS) This Quarter$1.51 EPS Expected for CVS Health (CVS) This Quarter
www.americanbankingnews.com - May 16 at 7:10 PM
Moody’s likes the upward financial trend at this Lakeland pharmacy benefits managerMoody’s likes the upward financial trend at this Lakeland pharmacy benefits manager
finance.yahoo.com - May 16 at 3:16 PM
UPDATE 1-U.S. hedge funds pile into health insurers, ignore Amazon threatUPDATE 1-U.S. hedge funds pile into health insurers, ignore Amazon threat
www.cnbc.com - May 16 at 5:02 AM
Rite Aid-Albertsons: Well Be Top 5 Health, Food And Wellness PlayerRite Aid-Albertsons: We'll Be Top 5 Health, Food And Wellness Player
finance.yahoo.com - May 15 at 3:03 PM
Trump Health Secretary Says Drugmakers Must Help Cut PricesTrump Health Secretary Says Drugmakers Must Help Cut Prices
www.msn.com - May 15 at 5:21 AM
CVS, Aetna Deal Has a 70% Chance of Closing. Here’s What Happens If It Doesn’t.CVS, Aetna Deal Has a 70% Chance of Closing. Here’s What Happens If It Doesn’t.
www.barrons.com - May 15 at 5:21 AM
Why CVS Health Corp Stock Rallied on Trumps Drug PlanWhy CVS Health Corp Stock Rallied on Trump's Drug Plan
finance.yahoo.com - May 15 at 5:21 AM
Thinking about buying stock in Apple, CVS Health Corp, Facebook, Symantec and Trade Desk?Thinking about buying stock in Apple, CVS Health Corp, Facebook, Symantec and Trade Desk?
www.prnewswire.com - May 14 at 3:10 PM
CVS responds to $40M Freds dealCVS responds to $40M Fred's deal
www.bizjournals.com - May 14 at 3:10 PM
CVS responds to $40M Fred's dealCVS responds to $40M Fred's deal
finance.yahoo.com - May 14 at 3:10 PM
CVS, Aetna Deal Has a 70% Chance of Closing. Heres What Happens If It Doesnt.CVS, Aetna Deal Has a 70% Chance of Closing. Here's What Happens If It Doesn't.
finance.yahoo.com - May 14 at 3:10 PM
Critical Review: CVS Health (CVS) vs. Diplomat Pharmacy (DPLO)Critical Review: CVS Health (CVS) vs. Diplomat Pharmacy (DPLO)
www.americanbankingnews.com - May 13 at 11:16 PM
Why Trumps Big Drug Price Speech Sent Health Care Stocks SoaringWhy Trump's Big Drug Price Speech Sent Health Care Stocks Soaring
fortune.com - May 13 at 3:15 PM
CVS HealthCVS Health
fortune.com - May 12 at 3:05 PM
Insiders Are Buying CVS on the Cheap -- You Should TooInsiders Are Buying CVS on the Cheap -- You Should Too
finance.yahoo.com - May 12 at 3:05 PM
CVS Health (CVS) Comments on Trump Administration Initiative to Reduce Drug CostsCVS Health (CVS) Comments on Trump Administration Initiative to Reduce Drug Costs
www.streetinsider.com - May 12 at 7:34 AM
Health Investors Rush Back as Trump Drug Speech Fuels RallyHealth Investors Rush Back as Trump Drug Speech Fuels Rally
www.msn.com - May 12 at 7:34 AM
[$$] Trump’s Plan to Cut Drug Prices Leaves Industry Relieved[$$] Trump’s Plan to Cut Drug Prices Leaves Industry Relieved
finance.yahoo.com - May 12 at 7:34 AM
Trump Trashes Pharmas Middlemen, but the Stocks RiseTrump Trashes Pharma's Middlemen, but the Stocks Rise
finance.yahoo.com - May 12 at 7:34 AM
[$$] Reckoning for Drug Middlemen Is Postponed, Not Canceled[$$] Reckoning for Drug Middlemen Is Postponed, Not Canceled
finance.yahoo.com - May 12 at 7:34 AM
DIGITAL HEALTH BRIEFING: UnitedHealthcare demonstrates benefit of value-based care - Walmart adds employee health tools - CVS partners with chatbotDIGITAL HEALTH BRIEFING: UnitedHealthcare demonstrates benefit of value-based care - Walmart adds employee health tools - CVS partners with chatbot
www.msn.com - May 11 at 3:21 PM
CVS Health Statement on Trump Administration Initiative to Reduce Drug CostsCVS Health Statement on Trump Administration Initiative to Reduce Drug Costs
finance.yahoo.com - May 11 at 3:21 PM
Behind the mega-hospital merger that will make this Northern California health system a $28 billion behemothBehind the mega-hospital merger that will make this Northern California health system a $28 billion behemoth
www.bizjournals.com - May 11 at 5:20 AM
We Are Playing The CVS HandWe Are Playing The CVS Hand
seekingalpha.com - May 11 at 5:20 AM
Earnings Show CVS Health Corp on Track To Benefit From TransformationEarnings Show CVS Health Corp on Track To Benefit From Transformation
investorplace.com - May 11 at 4:09 AM
CVS Health (CVS) versus Diplomat Pharmacy (DPLO) Financial AnalysisCVS Health (CVS) versus Diplomat Pharmacy (DPLO) Financial Analysis
www.americanbankingnews.com - May 10 at 7:29 PM
Should You Buy CVS Health Corporation (NYSE:CVS) At This PE Ratio?Should You Buy CVS Health Corporation (NYSE:CVS) At This PE Ratio?
finance.yahoo.com - May 9 at 3:13 PM
Reviewing CVS Health (CVS) & Diplomat Pharmacy (DPLO)Reviewing CVS Health (CVS) & Diplomat Pharmacy (DPLO)
www.americanbankingnews.com - May 9 at 11:50 AM
Trade Mistake 3: CVS Boredom TradeTrade Mistake 3: CVS Boredom Trade
seekingalpha.com - May 9 at 5:10 AM
CVS Health (CVS) Downgraded by ValuEngine to Strong SellCVS Health (CVS) Downgraded by ValuEngine to Strong Sell
www.americanbankingnews.com - May 8 at 3:23 PM
Buoy Health and CVS Health Provide Easy Access to Affordable CareBuoy Health and CVS Health Provide Easy Access to Affordable Care
www.bizjournals.com - May 8 at 3:02 PM
Jim Cramer Advises His Viewers On Prestige Brands, CVS Health And MoreJim Cramer Advises His Viewers On Prestige Brands, CVS Health And More
finance.yahoo.com - May 8 at 3:02 PM
Boston-based Buoy partners with CVS Health for Minute Clinic accessBoston-based Buoy partners with CVS Health for Minute Clinic access
www.bizjournals.com - May 8 at 3:02 PM
Why CVS Health Stock Gained 12% in AprilWhy CVS Health Stock Gained 12% in April
www.msn.com - May 8 at 3:02 PM
At HLTH 2018, CVS Health Chief Medical Officer Shows How Complementary Care Management at Retail Can Enhance Population HealthAt HLTH 2018, CVS Health Chief Medical Officer Shows How Complementary Care Management at Retail Can Enhance Population Health
finance.yahoo.com - May 8 at 3:02 PM
Fred's Confirms Sale of Specialty Pharmacy Unit, Stock UpFred's Confirms Sale of Specialty Pharmacy Unit, Stock Up
finance.yahoo.com - May 8 at 3:02 PM
Freds sells specialty pharmacy unit to CVSFred's sells specialty pharmacy unit to CVS
seekingalpha.com - May 8 at 5:16 AM
Freds reaches $40M deal with CVSFred's reaches $40M deal with CVS
www.bizjournals.com - May 8 at 5:16 AM
Cramer's lightning round: If you own stock in a gold comp...Cramer's lightning round: If you own stock in a gold comp...
finance.yahoo.com - May 8 at 5:16 AM
Cramers lightning round: If you own stock in a gold company, you can take profits hereCramer's lightning round: If you own stock in a gold company, you can take profits here
finance.yahoo.com - May 8 at 5:16 AM
Top Buys by Directors: Dormans $1.5M Bet on CVSTop Buys by Directors: Dorman's $1.5M Bet on CVS
www.nasdaq.com - May 7 at 3:14 PM

SEC Filings

CVS Health (NYSE:CVS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

CVS Health (NYSE:CVS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CVS Health (NYSE CVS) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.